Sorrentino D, Bartoli E
Department of Internal Medicine, University of Udine, Italy.
J Hepatol. 1996 Aug;25(2):178-82. doi: 10.1016/s0168-8278(96)80071-7.
BACKGROUND/AIMS: Controversy exists regarding the nature of the hepatocyte membrane transport system for sulfobromophthalein and other organic anions and its driving forces. Most studies have been performed in the absence of albumin, the plasma sulfobromophthalein binding protein, or using very low albumin concentrations. We have shown that in the latter case uptake kinetics reflect dissociation/diffusion events and not membrane transport. In contrast, without albumin very high sulfobromophthalein concentrations reach the cell surface and may overwhelm a high affinity/low capacity system operating in vivo. The aim of this study was to test the latter hypothesis.
Sulfobromophthalein uptake was measured by rapid filtration in isolated hepatocytes without albumin (up to 13 microM sulfobromophthalein) and with 600 microM albumin (sulfobromophthalein:albumin from 0.03:1 to 1:1), a physiologic setting which greatly reduces the unbound BSP concentration. Unbound sulfobromophthalein concentration was estimated according to a three binding site model.
In the absence of albumin, kinetic parameters for sulfobromophthalein uptake were similar to those reported in the literature (K(m):7.1 +/- 1.2 microM; V(max): 452 +/- 37 pmol/min/5 x 10(4) cells). In the presence of albumin, sulfobromophthalein uptake displayed much greater affinity and much lower capacity (K(m): 80 +/- 11 nM; V(max): 60 +/- 9 pmol/min/5 x 10(4) cells).
These findings suggest that in the absence of albumin, resulting high sulfobromophthalein concentrations overload (and make undetectable) a high affinity/low capacity system operating at physiologic albumin concentrations (i.e. at low unbound sulfobromophthalein concentrations). Previously characterized transport systems may be operating only under defined conditions. These findings could explain the apparent controversy regarding the nature of the sulfobromophthalein transport system and its driving forces.
背景/目的:关于磺溴酞钠及其他有机阴离子的肝细胞膜转运系统的性质及其驱动力存在争议。大多数研究是在没有血浆磺溴酞钠结合蛋白白蛋白的情况下进行的,或者使用的白蛋白浓度非常低。我们已经表明,在后一种情况下,摄取动力学反映的是解离/扩散事件,而非膜转运。相比之下,在没有白蛋白的情况下,非常高的磺溴酞钠浓度会到达细胞表面,并可能使体内运作的高亲和力/低容量系统不堪重负。本研究的目的是验证后一种假设。
通过快速过滤法测定分离的肝细胞对磺溴酞钠的摄取,一种情况是没有白蛋白(磺溴酞钠浓度高达13微摩尔),另一种情况是有600微摩尔白蛋白(磺溴酞钠与白蛋白的比例从0.03:1至1:1),这是一种生理环境,可大大降低未结合的磺溴酞钠浓度。根据三结合位点模型估算未结合的磺溴酞钠浓度。
在没有白蛋白的情况下,磺溴酞钠摄取的动力学参数与文献报道的相似(米氏常数:7.1±1.2微摩尔;最大反应速度:452±37皮摩尔/分钟/5×10⁴个细胞)。在有白蛋白的情况下,磺溴酞钠摄取表现出更高的亲和力和更低的容量(米氏常数:80±11纳摩尔;最大反应速度:60±9皮摩尔/分钟/5×10⁴个细胞)。
这些发现表明,在没有白蛋白的情况下,由此产生的高磺溴酞钠浓度会使在生理白蛋白浓度(即低未结合磺溴酞钠浓度)下运作的高亲和力/低容量系统过载(并使其无法检测到)。先前表征的转运系统可能仅在特定条件下运作。这些发现可以解释关于磺溴酞钠转运系统的性质及其驱动力的明显争议。